查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1785847

全球生物可吸收血管支架市場

Bioresorbable Vascular Scaffolds
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 265 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球生物可吸收血管支架市場規模將達到 6.4 億美元

全球生物可吸收血管支架市場規模預計在2024年達到4.225億美元，預計2024年至2030年期間的複合年成長率為7.2%，到2030年將達到6.4億美元。周邊動脈應用是本報告分析的細分市場之一，預計其複合年成長率為8.6%，到分析期結束時規模將達到3.769億美元。冠狀動脈應用細分市場在分析期間的複合年成長率預計為5.3%。

美國市場規模估計為 1.151 億美元，中國市場預計複合年成長率為 11.5%

美國生物可吸收血管支架市場規模預計2024年達到1.151億美元。作為世界第二大經濟體，中國市場規模預計在2030年達到1.362億美元，2024年至2030年的複合年成長率為11.5%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為3.5%和7.0%。在歐洲，德國的複合年成長率預計為4.8%。

全球生物可吸收血管支架市場—主要趨勢與促進因素摘要

為什麼生物可吸收血管支架在心血管治療上越來越受到青睞？

生物可吸收血管支架 (BVS) 正在徹底改變冠狀動脈疾病 (CAD) 的治療方式，它提供了一種臨時的結構解決方案，該解決方案會隨著時間的推移自然溶解，留下已癒合的血管。與永久留在動脈內的傳統金屬支架不同，生物可吸收支架旨在在關鍵的癒合期內提供機械支撐，然後逐漸分解以恢復正常的血管功能。這項新一代技術解決了永久性支架相關的長期併發症，包括晚期支架內血栓症、血管卡壓和發炎。

全球心血管疾病的流行，加上對微創治療日益成長的需求，推動了生物可吸收血管支架的應用。患者和心臟科醫生越來越青睞這些裝置，因為它們有可能改善長期療效並減少重複干預的需求。此外，聚合物科學和生物可吸收金屬合金的進步提高了支架的強度、分解控制和生物相容性，使生物可吸收支架 (BVS) 成為傳統支架的有前景的替代品。隨著醫療保健系統優先考慮以患者為中心且經濟高效的解決方案，生物可吸收支架正逐漸成為介入性心臟病學的關鍵創新。

科技進步如何改善生物可吸收血管支架？

生物材料、支架設計和藥物釋放型技術的創新推動了生物可吸收血管支架的進步，提高了其安全性、有效性和臨床性能。該領域最重要的進展之一是高強度生物可吸收聚合物的開發，例如聚左旋乳酸 (PLLA)，它能夠提供足夠的徑向支撐，同時抑制其隨時間推移的分解。此外，研究人員正在研究鎂基生物可吸收支架，這種支架具有更高的機械強度和快速吸收性，從而緩解了聚合物在動脈內長期存在所帶來的擔憂。

另一個突破是藥物釋放型塗層的引入，透過在早期癒合階段釋放抗增殖藥物（例如Sirolimus或Everolimus）來預防血管再阻塞。這些藥物釋放型生物可吸收支架已顯示出良好的臨床效果，可降低支架內血管再阻塞率，同時確保最佳的血管癒合。此外，計算建模和人工智慧驅動的最佳化技術增強了支架設計，使支架輪廓更纖薄，靈活性更高，從而減少了支架血栓症等併發症。這些技術進步正在進一步提高生物可吸收支架（BVS）的性能，並有望加速下一代設備在介入性心臟病學中的應用。

哪些市場趨勢推動了生物可吸收血管支架產業的發展？

冠狀動脈疾病盛行率的上升和經皮冠狀動脈介入治療 (PCI) 數量的增加是推動生物可吸收血管支架市場成長的最重要趨勢之一。由於心血管疾病仍然是全球最大的死亡原因，醫療保健提供者正在優先考慮能夠改善患者長期預後的創新解決方案。微創和患者友善治療方法的轉變也推動了生物可吸收血管支架的需求，而生物可吸收技術則能夠滿足減輕長期身體負擔這一更廣泛的目標。

影響市場的另一個關鍵趨勢是監管部門對生物可吸收支架的支持力道不斷增加。儘管前幾代生物可吸收支架（BVS）曾面臨支架血栓症形成和分解速度不理想的擔憂，但近年來材料科學和臨床數據的創新重新激發了監管機構和醫療專業人士的興趣。此外，生物可吸收技術的應用範圍已從冠狀動脈介入擴展到周邊動脈疾病(PAD) 和其他血管疾病，這正在開闢新的市場機會。隨著臨床試驗不斷檢驗BVS 的效用，以及更多下一代器械獲得監管部門的核准，生物可吸收支架市場在已開發經濟體和新興經濟體都將迎來顯著擴張。

影響生物可吸收血管支架市場未來發展的關鍵成長動力有哪些？

生物可吸收血管支架市場的成長受到多種因素的推動，包括技術進步、臨床應用的不斷增加以及對患者長期療效的日益關注。主要成長要素之一是心血管疾病負擔的不斷加重，這需要創新有效的治療方案。患者群體的不斷擴大，尤其是老化和高風險族群，預計將增加對生物可吸收支架的需求。

另一個影響市場的關鍵促進因素是醫療設備公司和學術機構對研發 (R&D) 的大力投入。支架設計、吸收動力學和藥物釋放型能力的不斷改進，正在提升生物可吸收支架 (BVS) 技術的臨床可行性。此外，醫療保健機構、醫療機構和生技公司之間的策略聯盟正在加速尖端生物可吸收支架的商業化。價值導向型醫療保健模式的日益普及，這種模式優先考慮患者的長期利益而非短期手術成本，預計也將推動對生物可吸收支架的需求。隨著這些因素持續推動創新和應用，生物可吸收血管支架將重新定義冠狀動脈和周邊動脈疾病管理的未來，改善患者預後，同時降低長期醫療成本。

部分

應用（周邊動脈應用、冠狀動脈應用）、最終用途（醫院最終用途、門診護理中心 (ACS) 最終用途、專科診所最終用途）

受訪公司範例

  • Abbott Cardiovascular
  • BD
  • Biotronik AG
  • Boston Scientific Corporation
  • Elixir Medical Corporation
  • Kyoto Medical Planning Co., Ltd
  • Meril Life Sciences
  • MicroPort
  • Reva Medical Inc
  • Shandong Huaan Biotechnology Co.,Ltd
  • Terumo Interventional Systems
  • WL Gore & Associates, Inc.
  • Zeus Inc

人工智慧整合

我們正在利用有效的專家內容和人工智慧工具來改變市場和競爭情報。

Global 特定產業產業SLM 的典型規範，而是建立了一個從世界各地專家收集的內容庫，包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP29609

Global Bioresorbable Vascular Scaffolds Market to Reach US$640.0 Million by 2030

The global market for Bioresorbable Vascular Scaffolds estimated at US$422.5 Million in the year 2024, is expected to reach US$640.0 Million by 2030, growing at a CAGR of 7.2% over the analysis period 2024-2030. Peripheral Artery Application, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$376.9 Million by the end of the analysis period. Growth in the Coronary Artery Application segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$115.1 Million While China is Forecast to Grow at 11.5% CAGR

The Bioresorbable Vascular Scaffolds market in the U.S. is estimated at US$115.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$136.2 Million by the year 2030 trailing a CAGR of 11.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 7.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Global Bioresorbable Vascular Scaffolds Market - Key Trends & Drivers Summarized

Why Are Bioresorbable Vascular Scaffolds Gaining Momentum in Cardiovascular Treatments?

Bioresorbable vascular scaffolds (BVS) are revolutionizing the treatment of coronary artery disease (CAD) by offering a temporary structural solution that naturally dissolves over time, leaving behind a healed vessel. Unlike traditional metallic stents, which remain permanently in the artery, bioresorbable scaffolds are designed to provide mechanical support during the critical healing phase and then gradually degrade, restoring natural vessel function. This next-generation technology addresses long-term complications associated with permanent stents, such as late-stent thrombosis, vessel caging, and inflammation.

The growing global prevalence of cardiovascular diseases, coupled with the increasing demand for minimally invasive procedures, has propelled the adoption of bioresorbable vascular scaffolds. Patients and cardiologists are increasingly favoring these devices due to their potential to improve long-term outcomes and reduce the need for repeat interventions. Additionally, advancements in polymer science and bioresorbable metal alloys are enhancing scaffold strength, degradation control, and biocompatibility, making BVS a promising alternative to traditional stents. As healthcare systems prioritize patient-centric and cost-effective solutions, BVS is emerging as a key innovation in interventional cardiology.

How Are Technological Advancements Improving Bioresorbable Vascular Scaffolds?

Innovations in biomaterials, scaffold design, and drug-eluting technology are driving the evolution of bioresorbable vascular scaffolds, improving their safety, efficacy, and clinical performance. One of the most significant advancements in this field is the development of high-strength bioresorbable polymers, such as poly-L-lactic acid (PLLA), which provide sufficient radial support while ensuring controlled degradation over time. Additionally, researchers are exploring magnesium-based bioresorbable scaffolds that offer improved mechanical strength and faster resorption, reducing concerns related to prolonged polymer presence in the arteries.

Another major breakthrough is the incorporation of drug-eluting coatings that help prevent restenosis by releasing antiproliferative agents such as sirolimus or everolimus during the initial healing phase. These drug-eluting bioresorbable scaffolds have demonstrated promising clinical outcomes by reducing in-stent restenosis rates while ensuring optimal vascular healing. Furthermore, computational modeling and AI-driven optimization techniques are enhancing scaffold design, leading to thinner strut profiles and improved flexibility, which reduce complications such as scaffold thrombosis. As these technological advancements continue to refine BVS performance, the adoption of these next-generation devices is expected to accelerate in interventional cardiology.

Which Market Trends Are Driving Growth in the Bioresorbable Vascular Scaffolds Industry?

The increasing prevalence of coronary artery disease and the rising number of percutaneous coronary interventions (PCIs) are among the most significant trends fueling the growth of the bioresorbable vascular scaffold market. With cardiovascular diseases remaining the leading cause of mortality worldwide, healthcare providers are prioritizing innovative solutions that improve long-term patient outcomes. The demand for BVS is also being driven by a shift toward minimally invasive and patient-friendly interventions, where bioresorbable technology aligns with the broader goal of reducing long-term foreign material presence in the body.

Another key trend shaping the market is the increasing regulatory support for bioresorbable scaffolds. While earlier-generation BVS faced concerns over scaffold thrombosis and suboptimal degradation rates, recent innovations in material science and clinical data have led to renewed interest from regulatory agencies and healthcare professionals. Additionally, the expansion of bioresorbable technology beyond coronary interventions-into peripheral artery disease (PAD) and other vascular conditions-is opening new market opportunities. As clinical trials continue to validate the benefits of BVS, and more next-generation devices receive regulatory approvals, the market is poised for significant expansion in both developed and emerging economies.

What Are the Key Growth Drivers Shaping the Future of the Bioresorbable Vascular Scaffolds Market?

The growth in the bioresorbable vascular scaffold market is driven by multiple factors, including technological advancements, increasing clinical adoption, and a growing emphasis on long-term patient outcomes. One of the primary growth drivers is the rising burden of cardiovascular diseases, which necessitates innovative and effective treatment options. As patient populations expand, particularly in aging demographics and high-risk groups, the demand for bioresorbable scaffolds is expected to increase.

Another crucial driver shaping the market is the strong investment in research and development (R&D) by medical device companies and academic institutions. Continuous improvements in scaffold design, resorption kinetics, and drug-eluting capabilities are enhancing the clinical feasibility of BVS technology. Additionally, strategic collaborations between healthcare providers, medical institutions, and biotech firms are accelerating the commercialization of advanced bioresorbable scaffolds. The increasing adoption of value-based healthcare models, which prioritize long-term patient benefits over short-term procedural costs, is also expected to boost the demand for BVS. As these factors continue to drive innovation and adoption, bioresorbable vascular scaffolds are set to redefine the future of coronary and peripheral artery disease management, improving patient outcomes while reducing long-term healthcare costs.

SCOPE OF STUDY:

The report analyzes the Bioresorbable Vascular Scaffolds market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Peripheral Artery Application, Coronary Artery Application); End-Use (Hospitals End-Use, Ambulatory Care Centers (ACS) End-Use, Specialty Clinics End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Abbott Cardiovascular
  • BD
  • Biotronik AG
  • Boston Scientific Corporation
  • Elixir Medical Corporation
  • Kyoto Medical Planning Co., Ltd
  • Meril Life Sciences
  • MicroPort
  • Reva Medical Inc
  • Shandong Huaan Biotechnology Co.,Ltd
  • Terumo Interventional Systems
  • W. L. Gore & Associates, Inc.
  • Zeus Inc

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Bioresorbable Vascular Scaffolds - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Burden of Cardiovascular Diseases Throws the Spotlight on Bioresorbable Vascular Scaffolds as a Revolutionary Stent Alternative
    • Shift Toward Minimally Invasive and Restorative Therapies Drives Demand for BVS in Coronary Interventions
    • Clinical Preference for Temporary Vessel Support Solutions Strengthens the Business Case for Bioresorbable Scaffolds
    • Limitations of Traditional Drug-Eluting Stents (DES) Expand Addressable Market Opportunity for BVS Technologies
    • Growing Emphasis on Natural Vessel Healing and Long-Term Vascular Restoration Fuels Adoption of BVS Devices
    • Technological Advancements in Polymer and Magnesium-Based Materials Propel Innovation in Scaffold Design and Performance
    • Increasing Use of Intravascular Imaging Techniques Enhances Precision Deployment and Optimized Outcomes of BVS
    • Rising Focus on Reducing Late-Stent Thrombosis Risk Spurs Clinical Interest in Fully Resorbable Scaffold Solutions
    • Next-Generation BVS Systems with Improved Radial Strength and Resorption Kinetics Accelerate Clinical Acceptance
    • Surge in Demand for Scaffold Solutions in Younger Patient Populations Propels Growth of Bioresorbable Stent Adoption
    • Healthcare System Focus on Reducing Long-Term Reintervention Rates Supports Broader Adoption of BVS
    • Emergence of Hybrid Scaffolds and Drug-Eluting Bioresorbable Technologies Opens New Avenues for Competitive Differentiation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Bioresorbable Vascular Scaffolds Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Bioresorbable Vascular Scaffolds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Bioresorbable Vascular Scaffolds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Peripheral Artery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Peripheral Artery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Peripheral Artery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Coronary Artery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Coronary Artery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Coronary Artery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Ambulatory Care Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: USA 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: Canada 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Japan 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: China 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Bioresorbable Vascular Scaffolds by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Europe 15-Year Perspective for Bioresorbable Vascular Scaffolds by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • FRANCE
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: France 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Germany 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Italy 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: UK 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 74: Spain Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Spain Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Spain 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 80: Russia Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Russia Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Russia 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Europe 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Bioresorbable Vascular Scaffolds by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Asia-Pacific 15-Year Perspective for Bioresorbable Vascular Scaffolds by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 101: Australia Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Australia Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Australia 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • INDIA
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 107: India Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: India Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: India 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 110: India Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 113: South Korea Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: South Korea Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: South Korea 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 119: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Asia-Pacific Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Asia-Pacific 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 125: Latin America Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 126: Latin America Historic Review for Bioresorbable Vascular Scaffolds by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Latin America 15-Year Perspective for Bioresorbable Vascular Scaffolds by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 134: Argentina Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Argentina Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Argentina 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 140: Brazil Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Brazil Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Brazil 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 146: Mexico Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Mexico Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Mexico 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Latin America Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Latin America 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 158: Middle East Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 159: Middle East Historic Review for Bioresorbable Vascular Scaffolds by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Middle East 15-Year Perspective for Bioresorbable Vascular Scaffolds by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 167: Iran Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Iran Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Iran 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 173: Israel Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Israel Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Israel 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 179: Saudi Arabia Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Saudi Arabia Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Saudi Arabia 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 185: UAE Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: UAE Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: UAE 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 191: Rest of Middle East Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Middle East Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Middle East 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030
  • AFRICA
    • Bioresorbable Vascular Scaffolds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 197: Africa Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Africa Historic Review for Bioresorbable Vascular Scaffolds by Application - Peripheral Artery Application and Coronary Artery Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Africa 15-Year Perspective for Bioresorbable Vascular Scaffolds by Application - Percentage Breakdown of Value Sales for Peripheral Artery Application and Coronary Artery Application for the Years 2015, 2025 & 2030
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Bioresorbable Vascular Scaffolds by End-Use - Hospitals End-Use and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Bioresorbable Vascular Scaffolds by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Ambulatory Care Centers for the Years 2015, 2025 & 2030

IV. COMPETITION